News
5 Surprising Benefits of Adding Protein Powder to Your Diet
Are you looking for an easy way to improve your nutrition, support muscle growth and kickstart your metabolism? Then, adding protein powder to your diet might be the answer. Protein powder is a fast-acting, nutrient-dense dietary supplement packed with...
Drug Research
NIIMBL Unveils 3 New Vaccine Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute's Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro...
Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...
Drug Research
Novo Nordisk to Expand R&D Presence in Greater Boston Area
Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, MA,...
Drug Research
Actylis Opens API Manufacturing Facility
Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021...
Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...
Clinical Trials
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal with catheter-directed thrombolysis (PE-TRACT) clinical trial.
The company claims that PE-TRACT will be the most rigorous...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















